HK1112843A1 - Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin - Google Patents

Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin

Info

Publication number
HK1112843A1
HK1112843A1 HK08107888.2A HK08107888A HK1112843A1 HK 1112843 A1 HK1112843 A1 HK 1112843A1 HK 08107888 A HK08107888 A HK 08107888A HK 1112843 A1 HK1112843 A1 HK 1112843A1
Authority
HK
Hong Kong
Prior art keywords
olanzapin
oral
spit out
disintegrating film
quickly disintegrating
Prior art date
Application number
HK08107888.2A
Other languages
English (en)
Inventor
Petra Obermeier
Thomas Kohr
Kai-Thomas Kramer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37156035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1112843(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of HK1112843A1 publication Critical patent/HK1112843A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK08107888.2A 2005-07-20 2008-07-16 Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin HK1112843A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033943A DE102005033943A1 (de) 2005-07-20 2005-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
PCT/EP2006/007177 WO2007009801A2 (de) 2005-07-20 2006-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender film für ein neuroleptikum

Publications (1)

Publication Number Publication Date
HK1112843A1 true HK1112843A1 (en) 2008-09-19

Family

ID=37156035

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08107888.2A HK1112843A1 (en) 2005-07-20 2008-07-16 Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin

Country Status (18)

Country Link
US (1) US20080200452A1 (es)
EP (1) EP1904029B2 (es)
JP (1) JP5551361B2 (es)
CN (1) CN101287445A (es)
AT (1) ATE496616T1 (es)
AU (1) AU2006271865B2 (es)
BR (1) BRPI0613683A2 (es)
CA (1) CA2615533C (es)
DE (2) DE102005033943A1 (es)
ES (1) ES2358607T5 (es)
HK (1) HK1112843A1 (es)
MX (1) MX2008000847A (es)
PL (1) PL1904029T5 (es)
PT (1) PT1904029E (es)
RU (1) RU2427374C2 (es)
SI (1) SI1904029T2 (es)
WO (1) WO2007009801A2 (es)
ZA (1) ZA200800976B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0906648A2 (pt) * 2008-01-31 2019-11-19 Mcneil Ppc Inc tiras de filme comestível para liberação imediata de ingredientes ativos
EP2674150A1 (de) * 2009-01-28 2013-12-18 Labtec GmbH Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5751868B2 (ja) * 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
EP2566467A1 (de) 2010-05-07 2013-03-13 Hexal Aktiengesellschaft Mucosaler film enthaltend zwei zuckeraustauschstoffe
DE102010049706A1 (de) 2010-10-28 2012-05-03 Hexal Ag Herstellung orodispersibler Filme
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP5257804B1 (ja) * 2011-12-09 2013-08-07 Ｄｉｃ株式会社 造膜助剤ならびにそれを含有する水性樹脂組成物及び鋼板表面処理剤
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
CN102920683B (zh) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 奥氮平口腔速溶膜
WO2014135967A1 (en) 2013-03-06 2014-09-12 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
EP3154529B1 (en) * 2014-06-10 2020-07-08 Capsugel Belgium NV Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
NZ727834A (en) * 2014-06-24 2020-08-28 Taho Pharmaceuticals Ltd Fast acting orally disintegrating film
CA2950495A1 (en) 2014-07-17 2016-01-21 Hexal Ag Orodispersible film
EP3226845A1 (en) 2014-12-04 2017-10-11 Capsugel Belgium NV Lipid multiparticulate formulations
US20170216220A1 (en) * 2016-02-03 2017-08-03 Intelgenx Corp. Loxapine film oral dosage form
US11648212B2 (en) * 2016-02-03 2023-05-16 Intelgenx Corp. Loxapine film oral dosage form
DE102017103346A1 (de) 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
CN107823191B (zh) * 2017-11-16 2021-04-09 广州迈达康医药科技有限公司 一种帕利哌酮口服速溶膜制剂及其制备工艺
GR20200100430A (el) * 2020-06-01 2022-01-13 Κυριακος Ηλια Κυπραιος Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους
KR102501784B1 (ko) * 2020-11-02 2023-02-20 아주대학교산학협력단 난용성 약물을 포함하는 구강 붕해 필름 제조방법
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317214A (en) * 1980-07-14 1982-02-23 Attinello John S Apparatus for simulating interference transmissions
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4820506A (en) * 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
AU3478200A (en) * 1999-02-02 2000-08-25 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices
BR0009437A (pt) * 1999-03-31 2002-01-15 Janssen Pharmaceutica Nv Amido pré-gelatinizado em uma formulação de liberação controlada
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6828308B2 (en) * 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
JP2002338456A (ja) * 2001-05-14 2002-11-27 ▲高▼田 ▲寛▼治 小腸粘膜付着性貼付剤Ｇａｓｔｒｏｉｎｔｅｓｔｉｎａｌｍｕｃｏａｄｈｅｓｉｖｅｐａｔｃｈｓｙｓｔｅｍ（ＧＩ−ＭＡＰＳ）の製造法
JP2003125679A (ja) * 2001-10-19 2003-05-07 Shimano Inc ベイトリール
US20040247649A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
JP2004043450A (ja) * 2002-05-16 2004-02-12 Kyukyu Yakuhin Kogyo Kk 速溶性フィルム状製剤
EP1413887A1 (en) * 2002-10-22 2004-04-28 Aventis Pharma S.A. Inhibitors of Src kinase for use in Alzheimer's disease
AU2003286796A1 (en) * 2002-10-31 2004-06-07 Umd, Inc. Therapeutic compositions for drug delivery to and through covering epithelia
JP4443903B2 (ja) * 2002-12-02 2010-03-31 救急薬品工業株式会社 積層フィルム状可食性口腔内投与剤の製造方法
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
AU2004233744A1 (en) * 2003-05-02 2004-11-11 Warner-Lambert Company Llc Fast dissolving orally consumable films containing a modified starch for improved heat and moisture resistance
AR045076A1 (es) * 2003-07-24 2005-10-12 Smithkline Beecham Plc Composicion de pelicula que se disuelve oralmente, pelicula multicomponente que se disuelve oralmente, uso de la composicion de pelicula y de la pelicula que se disuelve oralmente para preparar un medicamento, forma de dosificacion oral y procedimiento para preparar la composicion de pelicula que se
AU2004264974A1 (en) * 2003-08-15 2005-02-24 Arius Two, Inc. Adhesive bioerodible transmucosal drug delivery system
DK1695094T3 (da) * 2003-10-24 2013-09-16 Adhesives Res Inc Disintegrerende film til diagnostiske indretninger

Also Published As

Publication number Publication date
AU2006271865B2 (en) 2011-08-25
SI1904029T1 (sl) 2011-04-29
JP2009501752A (ja) 2009-01-22
JP5551361B2 (ja) 2014-07-16
EP1904029A2 (de) 2008-04-02
SI1904029T2 (sl) 2015-01-30
ES2358607T3 (es) 2011-05-12
EP1904029B2 (de) 2014-11-12
WO2007009801A2 (de) 2007-01-25
CN101287445A (zh) 2008-10-15
CA2615533A1 (en) 2007-01-25
ATE496616T1 (de) 2011-02-15
EP1904029B1 (de) 2011-01-26
ES2358607T5 (es) 2014-12-05
RU2008105830A (ru) 2009-11-10
DE102005033943A1 (de) 2007-02-22
PL1904029T5 (pl) 2015-05-29
PL1904029T3 (pl) 2011-06-30
US20080200452A1 (en) 2008-08-21
PT1904029E (pt) 2011-03-16
AU2006271865A1 (en) 2007-01-25
DE502006008816D1 (de) 2011-03-10
BRPI0613683A2 (pt) 2011-01-25
WO2007009801A3 (de) 2007-06-21
ZA200800976B (en) 2009-08-26
MX2008000847A (es) 2008-03-26
CA2615533C (en) 2014-04-08
RU2427374C2 (ru) 2011-08-27

Similar Documents

Publication Publication Date Title
HK1112843A1 (en) Oral, quickly disintegrating film, which cannot be spit out, containing olanzapin
WO2007009800A3 (de) Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel
WO2006081251A3 (en) Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
MX343314B (es) Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
MX2008007307A (es) Granulos/capsulas modificados que contienen ingrediente activo.
EP1919302B8 (en) Food comprising silicon
WO2005041924A3 (en) Administration of levodopa and carbidopa
EP2450360A3 (en) (S)-N-Methylnaltrexone
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
MX2007012623A (es) Inulina de cadena larga.
EP2476461A3 (en) Formulations For Cancer Treatment
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
UA88165C2 (en) Use of trisubstituted benzopyranones
GB0606848D0 (en) Product, method of manufacture and use
WO2008046865A3 (en) Long-term feed - elderly
MX2009003260A (es) Probioticos para el uso en la reduccion de la incidencia y duracion de la enfermedad.
MX2007011264A (es) Composiciones nutricionales para modular la biodisponibilidad de vitamina c.
SG165324A1 (en) Compositions and methods to counteract oral malodour
WO2005052140A3 (en) Multipotent postnatal stem cells from human periodontal ligament and uses thereof
MXPA05008902A (es) Soluciones de drogas en mentol.
NO20051473L (no) Behandling mot brekninger.
GB0327390D0 (en) Pharmaceutical formulations
MX2009001217A (es) Helado y formulaciones para helado que contienen maltitol.
WO2006020984A3 (en) Cyclosporin formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170720